Designing allosteric inhibitors of factor XIa. Lessons from the interactions of sulfated pentagalloylglucopyranosides. - Wikidata - wikimedia - TriplyDB

Designing allosteric inhibitors of factor XIa. Lessons from the interactions of sulfated pentagalloylglucopyranosides.

Designing allosteric inhibitors of factor XIa. Lessons from the interactions of sulfated pentagalloylglucopyranosides.

http://www.wikidata.org/entity/Q34435690

about

Factor XI and contact activation as targets for antithrombotic therapy Plasmin regulation through allosteric, sulfated, small molecules.Allosteric inhibition of factor XIa. Sulfated non-saccharide glycosaminoglycan mimetics as promising anticoagulants.Allosteric Inhibition of Factor XIIIa. Non-Saccharide Glycosaminoglycan Mimetics, but Not Glycosaminoglycans, Exhibit Promising Inhibition Profile.A molecular dynamics-based algorithm for evaluating the glycosaminoglycan mimicking potential of synthetic, homogenous, sulfated small molecules.Factor XIa inhibitors: A review of the patent literature.Factors XI and XII as Targets for New Anticoagulants.

P2860

Q27024190-2E92A1AC-9AF1-4FBB-8C41-3D316BAA9AEE Q35540006-FFE919F1-14F6-4123-8750-6B5627656341 Q35920828-B9B21FA1-6FA5-472A-AF45-C6456562FB74 Q36088633-C06C0951-DC8F-4F33-B1F8-5A27F2ED3889 Q36275692-764D31F7-CB86-42F4-AC2D-37407C59EE86 Q37087491-BA22B5DF-2018-4882-A886-580D57E9A4EA Q37662547-8BCFEC20-A1E3-4BCF-B78D-8E5E9ED837D1

P2860

Designing allosteric inhibitors of factor XIa. Lessons from the interactions of sulfated pentagalloylglucopyranosides.

http://www.wikidata.org/entity/Q34435690

description

2014 nî lūn-bûn

@nan

2014 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Designing allosteric inhibitor ...... pentagalloylglucopyranosides.

@ast

Designing allosteric inhibitor ...... pentagalloylglucopyranosides.

@en

Designing allosteric inhibitor ...... pentagalloylglucopyranosides.

@nl

type

label

Designing allosteric inhibitor ...... pentagalloylglucopyranosides.

@ast

Designing allosteric inhibitor ...... pentagalloylglucopyranosides.

@en

Designing allosteric inhibitor ...... pentagalloylglucopyranosides.

@nl

prefLabel

Designing allosteric inhibitor ...... pentagalloylglucopyranosides.

@ast

Designing allosteric inhibitor ...... pentagalloylglucopyranosides.

@en

Designing allosteric inhibitor ...... pentagalloylglucopyranosides.

@nl

P1433

Q34435690-93A03C63-39B5-4D32-8069-FF7E059DE08B

P1476

Q34435690-F6FA7544-F85B-492B-AB79-23356453D46A

P2093

Q34435690-55B28958-C2D8-4668-BBB0-1D62380087F7

Q34435690-E3BE4EB8-F9F5-4161-94D4-BBBBBE5D332A

P2860

Q34435690-02C02953-EC25-439E-B0D6-EDC18F050F8F

Q34435690-09331BF5-D6D3-4D05-9BB2-E4A2E8210240

Q34435690-098FEED4-48DA-445A-AC87-A41D93145B63

Q34435690-0C062CDE-C4AD-4B27-8822-5705D0D47E0F

Q34435690-0E66AA2F-FA50-4398-AD8A-6340B2924A7F

Q34435690-10C26194-FD1A-410D-A3F9-AD212A0522BB

Q34435690-18082FE6-871E-44EB-B9F3-C2717086611E

Q34435690-1AA030B4-4EE7-4619-81F3-827DFD72527A

Q34435690-1E65E6DD-9196-4AB5-BE9E-37B34EC55882

Q34435690-1EA63665-AC46-4B0C-9360-7BACD5554EEC

P304

Q34435690-C0A96749-840B-4798-B53E-84E2BCE0C531

P31

Q34435690-B7147451-B8BB-425A-8841-2D482CB20DE5

P356

Q34435690-8CB2BD58-7F65-483D-8169-64361EB96B1F

P407

Q34435690-8DB96B76-6B9F-41AD-A8CB-DAE13A9D5F4B

P433

Q34435690-D5A7674B-D51D-41A8-B43F-AA7660EE11EC

P478

Q34435690-1FBFF457-337B-4643-8608-1D47AEBB829E

P50

Q34435690-86DB628B-F654-47CD-B160-1D8D3911CAB8

Q34435690-8A50B17F-596A-436D-918F-AEC5704664BF

P577

Q34435690-95468C5A-354A-4F6C-A3F4-7AD8A7D8F78A

P5875

Q34435690-816DAD49-1543-40DB-82EE-64FD24FFFB7D

P698

Q34435690-95842C3F-310F-4C38-AC3C-A5AE94C23FF3

P921

Q34435690-BF1DBF51-742D-4533-9177-6ED8B57E295E

P932

Q34435690-B6E5115C-3D0C-43EB-8AB0-B15C5A92F938

P356

P1433

Journal of Medicinal Chemistry

P1476

Designing allosteric inhibitor ...... pentagalloylglucopyranosides.

@en

P2093

Rami A Al-Horani

http://www.w3.org/2001/XMLSchema#string

Umesh R Desai

http://www.w3.org/2001/XMLSchema#string

P2860

Rational design of potent, small, synthetic allosteric inhibitors of thrombin

Design, synthesis, and biological evaluation of peptidomimetic inhibitors of factor XIa as novel anticoagulants

Clavatadine A, a natural product with selective recognition and irreversible inhibition of factor XIa

Interaction of Thrombin with Sucrose Octasulfate

Tetrahydroquinoline derivatives as potent and selective factor XIa inhibitors

Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction

Effects of factor IX or factor XI deficiency on ferric chloride-induced carotid artery occlusion in mice

Designing Allosteric Regulators of Thrombin. Exosite 2 Features Multiple Subsites That Can Be Targeted by Sulfated Small Molecules for Inducing Inhibition

Interaction of antithrombin with sulfated, low molecular weight lignins: opportunities for potent, selective modulation of antithrombin function.

Sulfated, low-molecular-weight lignins are potent inhibitorsof plasmin, in addition to thrombin and factor Xa: Novel opportunity for controlling complex pathologies.

P304

4805-4818

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1021/JM500311E

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

57

http://www.w3.org/2001/XMLSchema#string

P50

Rami A Al-Horani

P577

2014-05-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

262451261

http://www.w3.org/2001/XMLSchema#string

P698

24844380

http://www.w3.org/2001/XMLSchema#string

P921

allosteric inhibitor

P932

4216218

http://www.w3.org/2001/XMLSchema#string